Acquisitions - Summary of Intangible Assets Acquired (Details) - USD ($) $ in Thousands |
Feb. 21, 2025 |
Jan. 23, 2025 |
|---|---|---|
| Molecular | ||
| Business Combination [Line Items] | ||
| Intangible assets, net | $ 3,200 | |
| Molecular | Developed technology | ||
| Business Combination [Line Items] | ||
| Intangible assets, net | $ 3,200 | |
| Estimated Useful Life (in years) | 13 years | |
| Officinae Bio | ||
| Business Combination [Line Items] | ||
| Intangible assets, net | $ 8,180 | |
| Officinae Bio | Developed technology | ||
| Business Combination [Line Items] | ||
| Intangible assets, net | $ 8,100 | |
| Estimated Useful Life (in years) | 8 years | |
| Officinae Bio | Customer relationships | ||
| Business Combination [Line Items] | ||
| Intangible assets, net | $ 80 | |
| Estimated Useful Life (in years) | 6 years |
| X | ||||||||||
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of identifiable finite-lived intangible asset acquired in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|